SIBUTRAMINE Name: Ngai Ka Chun (20) Yiu Ysz Shing (31)

Slides:



Advertisements
Similar presentations
Effects of Alcohol, Tobacco, and Stimulants
Advertisements

Stimulants “Chemical Uppers”.
Other Medicines. Andrenergic Antagonists (Blockers) Bind to receptor site but do not cause an action Bind to receptor site but do not cause an action.
1 Evaluation of Obesity Associate Prof. Dr. Memet IŞIK Ataturk University Medical Faculty Department of Family Medicine
Antiparkinsonian Agents Ch 14. Parkinson’s Disease Progressive, y.o. d/t imbalance between dopamine & acetylcholine Symptoms: Slowed movement.
Monoamine oxidase inhibitors Monoamine Oxidase Inhibitors (MAOIs) are a class of powerful antidepressant drugs. They are particularly effective in treating.
PSYCHOPATHOLOGY.  Developed in the 1960s  Monoamine-oxidase inhibitors (MAOIs)  Increase the amount of Noradrenaline (Norepinephrine) in the synapse.
Prescription Medications David L. Gee, PhD Professor of Food Science and Nutrition Central Washington University.
Biological Therapies for depression:
Chemically Modifying Behaviors Copyright 2010:PEER.tamu.edu.
Drug Side Effects: Adderall
Biological explanations of depression
Why do you want selective antagonists? Acebutolol is a cardioselective beta blocker. It is more suitable than non cardioselective beta blockers, if a patient.
Manic Depression By Jason Li + Seth Horan.
BODY WEIGHT CONTROL. Obesity  Obesity is the state of excess body fat stores.  Energy Intake > Energy consumption.  WHO states 1.5 billion obese population.
DIET PILLS Jennifer Qing. What are diet pills? Pills that claim to make you lose weight.
Depression A Pathopharmacological Approach. Depression is a serious medical disorder characterized by sadness and despondent behavior. It isn’t something.
THE PHARMACOLOGY OF OBESITY DR. HANIN OSAMA. DEFINITION OF OBESITY BMI (Grade 1, overweight) BMI (Grade 2, obese) BMI > 40 (Grade 3, Morbidly.
Treating Depression in the Elderly A Multi-disciplinary Approach 12/11/2003.
Depression in Norway By Jørgen and Philip.
Psychotherapeutic Drugs
EQ: WHAT ARE THE AFFECTS OF DEPRESSION? BELLRINGER: DO YOU KNOW SOMEONE WITH DEPRESSION? HOW DID THEY ACT? DEPRESSION BETH, BRIANNA AND AUTUMN.
What Therapies Are Used to Treat Psychological Problems?
Stimulants By: Ginny Strother. What is a stimulant?  Stimulants are substances that stimulate the activity of the central nervous system. They increase.
Amphetamine Group Members: Kwong Ka Yi Mak Cheuk Kin.
Management Of Depressive Disorders Pharmacologic Treatments For Depression Copyright © World Psychiatric Association.
I CAN Explain psychopharmacology Describe properties, use, and side effects of: Antipsychotic Medications Anti-depressants Anti-anxiety stimulants Copyright.
Regulatory History of Sibutramine Eric Colman, MD Division of Metabolism and Endocrinology Products CDER - FDA.
 Chemistry Project Sildenafil Group members: Cheng Siu Ting Tsang Ming Lap Wong Wai Ki.
Amphetamine Michelle Lubrano Teaching Concepts of Health Education I Drug Investigation Assignment Spring 2010.
ALLHAT Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial JAMA 2002;288:
 Stimulants are drugs that exert their action through excitation of the central nervous system. Psychic stimulants include caffeine, cocaine, and various.
Discuss prevention strategies and treatments for overeating and obesity.
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 24 Antidepressant Drugs.
Unit 3 – Neurobiology and Communication
 Disorders of mood ◦ found throughout history  unipolar or major depression  bipolar or manic depression.
O besity Obesity is a medical condition in which excess body fat has accumulated to the extent that it may have an adverse effect on health, leading to.
Anxiolytics and Other Agents Used to Treat Psychiatric Conditions
Cheuk Ka Lok (6) Hui Wai Yan (11) Lee Tsz Tung (16) F.7 AL Chemistry Sibutarmi ne.
Psychiatric Medications: Prescription Overload By: Benjamin Brandt.
Pharmacology of central Neurotransmitters Prof. Yieldez.
Chapter Depression Barbour, Hoffman, and Blumenthal C H A P T E R.
Antidepressants By: Janae Skeem. Causes of Depression Abuse (Physical, sexual, or emotional) Certain Medications Conflict Death or a loss Genetics Major.
 : Monoamine hypothesis of depression asserts that depression is caused by functional insufficiency of monoamine neurotransmitter (norepinephrine, serotonin.
Biological Treatment Biological treatments generally include the administering of medication. This is controversial. Why do you think that is?
Overweight and Underweight
By dr.safeyya alchalabi
ADHD.
Ch. 13: Biomedical Therapy: Biological Approaches to Treatment
OBESITY WORKSHOP.
The Biomedical Therapies
Biological treatment for OCD
Drugs for Weight Loss 1.
Nuno Sousa, Christer Löfkrantz and Millie Ottesen
Drugs, Shocking, and Surgery
AFFECTIVE DISORDERS Anxiety----uneasiness from apprehension and worry about possible events. Try psychotherapy first. benzodiazepenes: xanax/alprazolam.
Drug therapy for treating depression
Recap last lesson Fill in the blanks..
OBESITY 물리작업치료전공 강권영.
School of Pharmacy, University of Nizwa
Sympathomimetics Domina Petric, MD.
School of Pharmacy, University of Nizwa
PHARMACOTHERAPY - I PHCY 310
Managing Age-Related Clinical Issues in Hemophilia
CNS Stimulants Defination
Antidepressant drugs.
Copyright Notice This presentation is copyrighted by the Psychopharmacology Institute. Subscribers can download it and use it for professional use. The.
Treatment of depression
CNS Stimulants: Uses (p. 210)
Brain Meds 3/2/2019 Scientistmel.com Twitter.com/scientistmel
Presentation transcript:

SIBUTRAMINE Name: Ngai Ka Chun (20) Yiu Ysz Shing (31)

Introduction Chemical name: Sibutramine IUPAC name: {1-[1-(4-chloro-phenyl)-cyclobutyl]-3- methyl-butyl}-dimethyl-amine Sibutramine is a neurotransmitter reuptake inhibitor. It can reduce the reuptake of serotonin by53%, norepinephrine by54% and dopamine by16%. Serotonin can affect the appetite. Nowadays, its properties are not fully discovered. it can inhabit the uptake of serotonin; it should be an effective antidepressant. It is banned in 2010

Lead compound discovery 1.Since Serotonin can promote a feeling of wellbeing and happiness, scientists therefore do researches on Serotonin. 2. In1987, Buckett, W.R., Hopcroft, R.H., Luscombe, G.P., Thomas, P.C are the people who first discovered BTS (Sibutramine), a monoamine uptake inhibitor from 4-chlorobenzyl cyanide. 3. In1995, Kelly discovered that sibutramine can decrease an obese person’s weight. This makes it to become an anorexiant to help obese people to lose weight.

Molecular Modification

Formulation development Oral :Capsule Potential in treating diseases: 1. sexual dysfunction 2. addictive disorders 3. pulmonary hypertension 4. cardiovascular disease 5. Chronic Fatigue Syndrome 6. hyperactivity disorders 7. menstrual dysfunction 8. orthostatic hypotension.

Formulation development a number of clinically significant interactions: 1. Sibutramine and monoamine oxidase inhibitors (MAOIs, such as selegiline)monoamine oxidase inhibitorsselegiline 2. Increase the risk of serotonin syndromeserotonin syndrome 3. Sibutramine and certain medications used in the treatment of migraines—such as ergolines and triptansmigrainesergolinestriptans 4. Increase the risk for serotonin syndrome

Safety tests and human trials

Approval for marketing: Meridia Meridia 1. a Sibutramine product 2. Produced by Abbott of America. 3. Approved by the Food and Drug Administration in November For weight loss and maintenance of weight loss in obese people, as well as in certain overweight people with other risks for heart disease

Approval for marketing: Side effects: Side effects: 1. cardiovascular events cardiovascular events 2. Increases the risk of heart attacksheart attacks 3. Increase the risk of strokes in patients with a history of cardiovascular disease. Increase the risk of strokes 4. Increase blood pressure and pulseblood pressure

The End The End!